CreditReports.dk
HomeScreen companies

Tetra Pharm Technologies ApS Financials, key figures and credit report

CVR number: 40738223 Established 2019 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Ørestads Boulevard 108, 2300 København S jesper@tetrapharm.eu tel: 29737073 https://www.tetrapharm.eu/
Gross profit -17 669.0 kDKK FY 2025 +38.2% vs 2024
EBIT -55 441.7 kDKK FY 2025 +9% vs 2024
Net debt 26 274.1 kDKK FY 2025 +777.8% vs 2024
Quick ratio 1.4 FY 2025 -1.7 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit3 208.29584.76-28 578.57-17 669.01
Costs of management-12 871.24-15 785.76
Costs of distribution-8 067.08-23 615.71
Employee benefit expenses-3 534.92-28 432.23-34 800.41
Total depreciation-87.60-2 319.91-3 898.19-2 972.27
EBIT- 414.24-20 938.32-38 816.71-60 908.99-55 441.69
Other financial income0.03422.78159.950.24
Other financial expenses-87.64-58.52-6.94- 117.03-2 648.16
Pre-tax profit- 501.87-20 996.81-38 400.87-60 866.06-58 089.60
Income taxes807.471 432.645 454.005 652.355 500.00
Net earnings305.59-19 564.18-32 946.87-55 213.71-52 589.60

Assets (kDKK)

2021
2022
2023
2024
2025
Development expenditure3 168.39
Intangible assets total3 168.39
Buildings580.013 583.9114 174.6215 157.605 364.38
Machinery and equipment138.96
Tangible assets total718.973 583.9114 174.6215 157.605 364.38
Investments total922.31916.331 133.142 069.493 391.61
Non-current other receivables3 859.28
Long term receivables total3 859.28
Semifinished products3 048.97
Raw materials and consumables529.43
Inventories total3 048.97529.43
Current trade debtors1 180.011 120.33
Prepayments and accrued income188.41595.12
Current other receivables311.221 213.592 739.963 305.67645.33
Current deferred tax assets1 060.692 150.217 604.215 500.005 500.00
Short term receivables total1 371.903 363.7910 344.1710 174.097 860.77
Cash and bank deposits5 198.4060 916.548 927.623 876.445 423.34
Cash and cash equivalents5 198.4060 916.548 927.623 876.445 423.34
Balance sheet total (assets)18 288.2368 780.5834 579.5531 277.6222 569.53

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital48.0862.3962.3967.5967.59
Share premium account15 027.8690 009.5990 009.59139 875.60139 875.60
Other reserves2 471.36
Retained earnings-4 066.24-5 473.13-25 037.30-57 984.17- 113 197.88
Profit of the financial year305.59-19 564.18-32 946.87-55 213.71-52 589.60
Shareholders equity total13 786.6565 034.6832 087.8126 745.31-25 844.29
Provisions697.03
Non-current trade creditors194.89
Non-current owed to group member2 637.6330 288.34
Non-current deferred tax liabilities972.048 730.20
Non-current liabilities total3 804.5539 018.54
Current loans from credit institutions1 128.08
Current trade creditors2 478.031 332.203 238.892 396.24
Current owed to participating281.03
Other non-interest bearing current liabilities1 267.871 159.531 293.425 589.93
Current liabilities total3 745.902 491.734 532.319 395.28
Balance sheet total (liabilities)18 288.2368 780.5834 579.5531 277.6222 569.53
Page generated